New study links blood markers to kidney disease progression in ADPKD
NCT ID NCT05193981
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how certain blood chemicals and blood vessel function relate to kidney disease severity in people with early-stage Autosomal Dominant Polycystic Kidney Disease (ADPKD). Researchers will measure homocysteine levels and blood vessel health in 80 participants aged 15-40. The goal is to find markers that can predict how fast the disease progresses, which may help guide future treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Thyroid hormones may hold clues to kidney disease progression
- Could zapping kidney nerves tame tough blood pressure in polycystic kidney disease?
- Diabetes drug metformin tested as new weapon against kidney disease
- Parkinson's drug repurposed to fight kidney disease?
- New drug PB shows promise for slowing excessive urination in kidney patients
- Scientists hunt for hidden mutations behind polycystic kidney disease